Literature DB >> 19401161

GABA(A) receptors in the lateral hypothalamus as mediators of satiety and body weight regulation.

Christine I Turenius1, Myat M Htut, Daniel A Prodon, Priscilla L Ebersole, Phuong T Ngo, Raul N Lara, Jennifer L Wilczynski, B Glenn Stanley.   

Abstract

In the lateral hypothalamus (LH), the inhibitory amino acid neurotransmitter, GABA, has had a long-standing presumptive role as an inhibitor of food intake. However, minimal investigation has been focused on GABA, especially as compared to the attention received by many peptide transmitters. To begin to address this deficiency in the understanding of the role of GABA in the LH and feeding, we report that antagonism of GABA(A) receptors in the rat LH elicits feeding, consistent with previous findings, and provide evidence for the behavioral selectivity of this effect. We extend previous findings that activation of LH GABA(A) receptors suppresses feeding, in particular by showing that nighttime and deprivation-induced eating are dramatically suppressed. Finally, we show that chronic activation, but not blockade, of the LH GABA(A) receptors leads to a reduction in 24 h food intake with concomitant body weight loss. These data collectively suggest that activation of GABA(A) receptors plays a fundamental role in controlling food intake and body weight, a role that has previously been somewhat underestimated.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19401161     DOI: 10.1016/j.brainres.2009.01.016

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  16 in total

Review 1.  The ventral pallidum: Subregion-specific functional anatomy and roles in motivated behaviors.

Authors:  David H Root; Roberto I Melendez; Laszlo Zaborszky; T Celeste Napier
Journal:  Prog Neurobiol       Date:  2015-04-06       Impact factor: 11.685

2.  Evidence that the nucleus accumbens shell, ventral pallidum, and lateral hypothalamus are components of a lateralized feeding circuit.

Authors:  Thomas R Stratford; David Wirtshafter
Journal:  Behav Brain Res       Date:  2011-10-15       Impact factor: 3.332

Review 3.  Melanocortin neurons: Multiple routes to regulation of metabolism.

Authors:  Wen-Jie Shen; Ting Yao; Xingxing Kong; Kevin W Williams; Tiemin Liu
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-05-09       Impact factor: 5.187

Review 4.  Neurobiology of consummatory behavior: mechanisms underlying overeating and drug use.

Authors:  Jessica R Barson; Irene Morganstern; Sarah F Leibowitz
Journal:  ILAR J       Date:  2012

5.  Effect of manganese chloride on the neurochemical profile of the rat hypothalamus.

Authors:  Nathalie Just; Cristina Cudalbu; Hongxia Lei; Rolf Gruetter
Journal:  J Cereb Blood Flow Metab       Date:  2011-06-29       Impact factor: 6.200

6.  The inhibitory circuit architecture of the lateral hypothalamus orchestrates feeding.

Authors:  Joshua H Jennings; Giorgio Rizzi; Alice M Stamatakis; Randall L Ung; Garret D Stuber
Journal:  Science       Date:  2013-09-27       Impact factor: 47.728

7.  Neuronal connections of the central amygdalar nucleus with refeeding-activated brain areas in rats.

Authors:  Györgyi Zséli; Barbara Vida; Anett Szilvásy-Szabó; Mónika Tóth; Ronald M Lechan; Csaba Fekete
Journal:  Brain Struct Funct       Date:  2017-08-29       Impact factor: 3.270

8.  Lateral Hypothalamus GABAergic Neurons Modulate Consummatory Behaviors Regardless of the Caloric Content or Biological Relevance of the Consumed Stimuli.

Authors:  Montserrat Navarro; Jeffrey J Olney; Nathan W Burnham; Christopher M Mazzone; Emily G Lowery-Gionta; Kristen E Pleil; Thomas L Kash; Todd E Thiele
Journal:  Neuropsychopharmacology       Date:  2015-10-07       Impact factor: 7.853

9.  Clinical utility of phentermine/topiramate (Qsymia™) combination for the treatment of obesity.

Authors:  Jin Hee Shin; Kishore M Gadde
Journal:  Diabetes Metab Syndr Obes       Date:  2013-04-08       Impact factor: 3.168

Review 10.  Cardiovascular effects of phentermine and topiramate: a new drug combination for the treatment of obesity.

Authors:  Jens Jordan; Arne Astrup; Stefan Engeli; Krzysztof Narkiewicz; Wesley W Day; Nick Finer
Journal:  J Hypertens       Date:  2014-06       Impact factor: 4.844

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.